← FDA DRUG APPROVALS

FDA ANDA · ANDA070228

DIAZEPAM

Sponsor: PH HEALTH

APPLICATION
ANDA070228
TYPE
ANDA
ORIGINAL APPROVAL
1985-09-26
LATEST ACTION
1997-12-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DIAZEPAMDiscontinued
DIAZEPAM 5MG · TABLET · ORAL
DIAZEPAMDiscontinued
DIAZEPAM 10MG · TABLET · ORAL
DIAZEPAMDiscontinued
DIAZEPAM 2MG · TABLET · ORAL

Approval history

1997-12-05Manufacturing (CMC) · Supplement 14AP
1997-11-19Manufacturing (CMC) · Supplement 13AP
1997-11-19Labeling · Supplement 11AP
1997-11-19Manufacturing (CMC) · Supplement 12AP
1994-08-25Labeling · Supplement 9AP
1989-05-19Labeling · Supplement 8AP
1988-06-14Labeling · Supplement 7AP
1987-11-17Manufacturing (CMC) · Supplement 6AP
1987-08-26Manufacturing (CMC) · Supplement 4AP
1987-08-26Manufacturing (CMC) · Supplement 5AP
1987-03-24Manufacturing (CMC) · Supplement 3AP
1987-03-24Manufacturing (CMC) · Supplement 1AP
1985-09-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →